Health
Preclinical data for the COVID-19 vaccine candidate shows efficacy and benefits – AlKhaleej Today
Preclinical data for the COVID-19 vaccine candidate shows efficacy and benefits
Photo credit: CC0 Public Domain
A COVID-19 vaccine candidate that underwent extensive preclinical testing at the University of Alabama in Birmingham during the spring and summer shows strong preclinical immune responses including several that differentiate it from other COVID-19 vaccine approaches, according to a preprint stored in the BioRxiv repository differ this week.
Partial preclinical results were announced in July and August by Maryland-based Altimmune Inc., a clinical-stage biopharma…
-
Business21 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News21 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News22 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News19 hours agoSudden death investigation, Maroochydore – Sunshine Coast